R. Fernꢀndez de la Pradilla et al.
2.37 (s, 3H; Me-pTol), 2.57 (ddd, 1H, J=16.3, 7.6, 2.4 Hz; H-2), 2.73
(ddd, 1H, J=16.3, 6.1, 2.2 Hz; H-2), 3.13 (m, 1H; H-3), 6.96 (s, 1H; H-
5), 7.25 (d, 2H, J=8.3 Hz), 7.27–7.44 (m, 5H), 7.50 (d, 2H, J=8.1 Hz),
9.70 ppm (t, 1H, J=2.3 Hz; H-1); DNOE between H-5/H-2 (2.73 ppm):
2.6%, H-5/H-2 (2.57 ppm): 1.3%, H-3/H-1: 1.3%; 1H NMR (C6D6,
300 MHz): d=0.59 (t, 3H, J=7.1 Hz; Me-nBu), 0.45–0.95 (m, 4H; nBu),
1.00–1.25 (m, 2H; nBu), 1.92 (s, 3H; Me-pTol), 2.28 (ddd, 1H, J=16.5,
7.4, 2.1 Hz; H-2), 2.60 (ddd, 1H, J=16.4, 6.2, 2.1 Hz; H-2), 3.27 (m, 1H;
H-3), 6.68 (s, 1H; H-5), 6.80 (d, 2H, J=8.0 Hz), 7.06–7.10 (m, 3H), 7.36
(d, 2H, J=7.3 Hz), 7.45 (d, 2H, J=8.3 Hz), 9.62 ppm (t, 1H, J=2.1 Hz;
H-1); 13C NMR (50 MHz): d=13.7 (Me-nBu), 21.2 (Me-pTol), 22.2, 28.8,
30.5, 34.5, 51.0 (C-2), 124.4 (2 C), 128.6 (2 C), 129.6 (2C), 129.7 (2C),
134.3, 135.7, 139.4, 141.0, 149.2, 201.9 ppm (CHO); IR (CCl4): n˜ =3000,
2980, 2920, 2880, 2820, 2680, 1700, 1580, 1470, 1420, 1370, 1150, 1060,
1020, 990, 890, 770, 730, 620, 600 cmÀ1; MS (EI, 70 eV): m/z (%): 215,
171, 140, 129, 117, 105, 91 (100), 77, 65, 55; elemental analysis calcd (%)
for C22H26O2S: C 75.54, H 7.39, S 9.04; found: C 75.72, H 7.18, S 8.83.
(%): 355 (100) [M+1]+, 256, 215, 178; elemental analysis calcd (%) for
C22H26O2S: C 74.54, H 7.39, S 9.04; found: C 74.23, H 7.52, S 9.27.
Data for 35: Rf =0.50 (30% EtOAc/hexane); 1H NMR (CDCl3,
300 MHz): d=0.91 (t, 3H, J=7.2 Hz; Me-nBu), 1.31–1.60 (m, 6H; nBu),
2.58 (ddd, 1H, J=16.5, 6.3, 2.0 Hz; H-2), 2.66 (ddd, 1H, J=16.6, 7.6,
2.1 Hz; H-2), 3.07 (quint, 1H, J=7.4 Hz; H-3), 7.25–7.28 (m, 3H), 7.35–
7.38 (m, 2H), 9.85 ppm (t, 1H, J=2.3 Hz; H-1); 13C NMR (50 MHz) d=
14.0 (Me-nBu), 22.4, 26.8, 29.4, 34.7, 48.6 (C-2), 91.1, 91.6, 127.9 (2C),
128.2 (2C), 131.5, 131.6 ppm; IR (CCl4): n˜ =3030, 2920, 2890, 2820, 2680,
1710, 1580, 1470, 1450, 1420, 1330, 1050, 1010, 670 cmÀ1; MS (APCI): m/z
(%): 256 (100) [M+CH3CN]+, 215, 171, 138, 105.
Data for ent-31a: Data for ent-31a is identical to that described above
for 31a except for the opposite optical rotation.
Sigmatropic rearrangement of 26a: Synthesis of (Æ)-(3S,SS)-4-(Z)-3-n-
butyl-5-phenyl-4-(p-tolylsulfinyl)pent-4-enal (ent-32a) and (Æ)-(3R,SS)-4-
(E)-3-n-butyl-5-phenyl-4-(p-tolylsulfinyl)pent-4-enal (34a): From acrylate
26a (186 mg, 0.45 mmol), by following the general procedure (1268C,
2 h), a 73:24:2:1 mixture of 34a, ent-32a, ent-33a, and 35 was obtained.
Purification by chromatography (5–30% EtOAc/hexane) afforded ent-
Sigmatropic rearrangement of 22a: Synthesis of (À)-(3S,SS)-4-(Z)-3-n-
butyl-5-phenyl-4-(p-tolylsulfinyl)pent-4-enal (ent-32a) and (+)-(3R,SS)-4-
(E)-3-n-butyl-5-phenyl-4-(p-tolylsulfinyl)pent-4-enal (34a): From acrylate
22a (100 mg, 0.27 mmol), by following the general procedure (1348C,
3 h), a 70:23:4:3 mixture of aldehydes ent-32a, 34a, 35, and ent-31a was
obtained. Purification by chromatography afforded 35 (2 mg) and ent-32a
(55 mg, 0.155 mmol, 57%), both as colorless oils, and 34a (21 mg,
0.059 mmol, 22%) as a white solid (Æ) that was recrystallized from
Et2O/hexane, or as a colorless oil (+). In a previous experiment, from
22a (54 mg, 0.130 mmol) at a higher temperature and with a longer reac-
tion time (1428C, 6 h) a 68:26:15:8 mixture of aldehydes ent-32a, 34a, 35,
and ent-31a was obtained. Purification by chromatography afforded pure
35 (4 mg, 0.018 mmol, 14%), ent-32a (24 mg, 0.068 mmol, 52%), and a
65:15 mixture of 34a and ent-31a (8 mg, 0.022 mmol, 17%). Separation
of ent-31a and 34a was achieved by preparative TLC (2% EtOAc/
CHCl3).
32a (28 mg, 0.08 mmol, 18%) as
a colorless oil and 34a (90 mg,
0.025 mmol, 56%) as a colorless oil that was crystallized as a white solid
from EtOAc/hexane.
Sigmatropic rearrangement of 27a: Synthesis of (Æ)-(3R,SS)-4-(Z)-3-n-
butyl-5-phenyl-4-(p-tolylsulfinyl)pent-4-enal (31a) and (Æ)-(3S,SS)-4-(E)-
3-n-butyl-5-phenyl-4-(p-tolylsulfinyl)pent-4-enal (33a): From acrylate 27a
(161 mg, 0.39 mmol), by following the general procedure (1208C, 3 h), an
88:8:2:2 mixture of 33a, 31a, ent-34a, and 35 was obtained. Purification
by chromatography (0–10% CH2Cl2) afforded 33a (97 mg, 0.27 mmol,
69%) as a white solid that was recrystallized from Et2O/hexane and 31a
(7 mg, 0.017 mmol, 5%) as a colorless oil.
Data for 33a: M.p. 72–738C; Rf =0.20 (30% EtOAc/hexane); 1H NMR
(CDCl3, 300 MHz): d=0.70 (t, 3H, J=6.8 Hz; Me-nBu), 0.93–1.18 (m,
4H; nBu), 1.28 (m, 1H; nBu), 1.34–1.47 (m, 1H; nBu), 2.12 (ddd, 1H,
J=17.7, 8.1, 1.6 Hz; H-2), 2.21 (ddd, 1H, J=17.7, 6.0, 0.8 Hz; H-2), 2.40
(s, 3H; Me-pTol), 3.43 (ddt, 1H, J=8.3, 6.0, 5.9 Hz; H-3), 7.28–7.40 (m,
7H), 7.61 (d, 2H, J=8.1 Hz), 7.61 (s, 1H; H-5), 9.30 ppm (s, 1H; H-1);
13C NMR (50 MHz): d=13.7 (Me-nBu), 21.5 (Me-pTol), 22.3, 29.4, 32.4,
33.2, 48.4 (C-2), 126.4 (2C), 128.2, 128.59 (2C), 128.60 (2C), 130.1 (2C),
132.0, 134.9, 140.3, 142.5, 148.1, 200.1 ppm (CHO); IR (KBr): n˜ =2927,
1718, 1493, 1455, 1079, 1040, 815, 767, 702, 623, 517 cmÀ1; MS (ES): m/z
(%): 409 (100), 377 [M+Na]+, 355 [M+1]+; elemental analysis calcd (%)
for C22H26O2S: C 74.54, H 7.39, S 9.05; found: C 74.27, H 7.12, S 9.07.
Data for ent-32a: Rf =0.45 (2ꢃ30% EtOAc/hexane); [a]2D0 =À397.2 (c=
1.50 in CHCl3); 1H NMR (CDCl3, 400 MHz): d=0.87 (t, 3H, J=7.1 Hz;
Me-nBu), 1.27–1.37 (m, 4H; nBu), 1.52–1.65 (m, 2H; nBu), 1.93 (ddd,
1H, J=16.1, 6.4, 2.6 Hz; H-2), 2.16 (ddd, 1H, J=16.1, 7.8, 2.5 Hz; H-2),
2.35 (s, 3H; Me-pTol), 3.25 (quint, 1H, J=7.1 Hz; H-3), 6.95 (s, 1H; H-
5), 7.23 (d, 2H, J=7.9 Hz), 7.33–7.43 (m, 5H), 7.50 (d, 2H, J=7.9 Hz),
1
8.90 ppm (t, 1H, J=2.5 Hz; H-1); H NMR (C6D6, 300 MHz): d=0.90 (t,
3H, J=7.0 Hz; Me-nBu), 1.25–1.49 (m, 7H; nBu), 1.55–1.63 (m, 1H;
nBu), 1.74 (ddd, 1H, J=16.0, 7.1, 2.8 Hz; H-2), 1.89 (s, 3H; Me-pTol),
1.92 (ddd, 1H, J=16.1, 7.4, 2.1 Hz, H-2), 3.38 (quint, 1H, J=6.8 Hz; H-
3), 6.68 (s, 1H; H-5), 6.80 (d, 1H, J=8.4 Hz), 7.03–7.15 (m, 3H), 7.37–
7.40 (m, 2H), 7.45 (d, 2H, J=8.3 Hz), 8.71 ppm (t, 1H, J=2.4 Hz; H-1);
DNOE between H-5/H-2 (1.93 ppm): 3.1%, H-2/H-5: 3.9%, H-5/H-3:
0.8%, H-5/H-1: 0.4%; 13C NMR (50 MHz): d=13.9 (Me-nBu), 21.3 (Me-
pTol), 22.6, 29.1, 29.9, 36.8, 49.4 (C-2), 142.2 (2C), 128.6 (2C), 129.6
(2C), 129.8 (2C), 132.4, 134.2, 135.7, 139.5, 141.1, 149.5, 200.1 ppm
(CHO); IR (CCl4): n˜ =3000, 2980, 2920, 2880, 2820, 2680, 1700, 1580,
Sigmatropic rearrangement of 23: Synthesis of (Æ)-4-(Z)-3-n-butyl-5-
phenyl-4-(p-tolylsulfenyl)pent-4-enal (36) and (Æ)-4-(E)-3-n-butyl-5-
phenyl-4-(p-tolylsulfenyl)pent-4-enal (37): From acrylate 23 (20 mg,
0.05 mmol), by following the general procedure (1348C, 1 h 15 min), a
93:7 mixture of aldehydes 36 and 37 was obtained. Purification by chro-
matography (2% EtOAc/hexane) afforded a mixture of 36 and 37 (5 mg,
0.015 mmol, 30%) and pure 36 (10 mg, 0.029 mmol, 58%) as a colorless
oil.
1470, 1420, 1370, 1280, 1150, 1060, 1020, 990, 900, 790, 730, 670, 600 cmÀ1
;
1
Data for 36: Rf =0.12 (2% EtOAc/hexane); H NMR (CDCl3, 300 MHz):
MS (APCI): m/z (%): 355 (100) [M+1]+, 260; MS (EI, 70 eV): m/z (%):
215, 171, 140, 129, 117, 105, 91 (100), 77, 65, 55, 41; elemental analysis
calcd (%) for C22H26O2S: C 74.54, H 7.39, S 9.04; found: C 74.77, H 7.07,
S 9.40.
d=0.85 (t, 3H, J=6.9 Hz; Me-nBu), 1.17–1.29 (m, 4H; nBu), 1.46 (m,
1H; nBu), 1.66 (m, 1H; nBu), 2.27 (s, 3H; Me-pTol), 2.47 (ddd, 1H, J=
16.5, 6.5, 2.1 Hz; H-2), 2.70 (ddd, 1H, J=16.5, 7.3, 2.3 Hz; H-2), 2.87 (m,
1H; H-3), 6.82 (s, 1H; H-5), 7.03 (d, 2H, J=8.5 Hz), 7.17 (d, 2H, J=
8.2 Hz), 7.20–7.31 (m, 3H), 7.56 (m, 2H), 9.59 ppm (t, 1H, J=2.1 Hz; H-
1); 13C NMR (50 MHz): d=14.0 (Me-nBu), 21.1 (Me-pTol), 22.6, 29.1,
33.8, 41.8, 48.4 (C-2), 127.5, 128.0 (2C), 129.4 (2C), 129.8 (2C), 130.5,
130.7 (2C), 133.4, 136.1, 136.9, 137.3, 201.9 ppm (CHO); IR (film): n˜ =
3021, 2927, 2857, 2717, 1724, 1595, 1491, 1445, 808, 752, 694 cmÀ1; MS
(APCI): m/z (%): 339 (100) [M+1]+, 321, 215, 173; elemental analysis
calcd (%) for C22H26OS: C 78.06, H 7.74, S 9.47; found: C 78.32, H 7.92,
S 9.75.
Data for 34a: M.p. (Æ) 65–668C; Rf =0.28 (2ꢃ30% EtOAc/hexane);
[a]2D0 =+29.3 (c=0.45 in CHCl3); 1H NMR (CDCl3, 300 MHz): d=0.67
(t, 3H, J=6.9 Hz; Me-nBu), 0.80–1.30 (m, 4H; nBu), 1.26 (m, 2H; nBu),
2.39 (s, 3H; Me-pTol), 2.42 (dd, 2H, J=7.6, 1.5 Hz; H-2), 3.19 (quint,
1H, J=7.3 Hz; H-3), 7.27–7.79 (m, 7H), 7.53 (s, 1H; H-5), 7.59 (d, 2H,
J=8.3 Hz), 9.25 ppm (t, 1H, J=1.5 Hz; H-1); DNOE between H-3/H-1:
2.6%, H-3/H-pTol ortho: 1.3%, H-1/H-pTol ortho: 1.9%, H-1/H-3:
3.0%, H-1/H-2: 1.9%; 13C NMR (75 MHz): d=13.7 (Me-nBu), 21.4 (Me-
pTol), 22.3, 29.6, 32.7, 34.1, 47.7 (C-2), 125.9 (2C), 128.1, 128.5 (2C),
128.6 (2C), 129.9 (2C), 132.7, 135.1, 139.9, 142.1, 148.6, 200.3 ppm
(CHO); IR (CCl4): n˜ =3000, 2920, 2890, 2820, 2680, 1700, 1580, 1470,
1430, 1360, 1240, 1060, 1030, 780, 740, 680, 600 cmÀ1; MS (APCI): m/z
Synthesis of (Æ)-4-(E)-3-n-butyl-5-phenyl-4-(p-tolylsulfonyl)pent-4-enal
(39a): From acrylate 30 (30 mg, 0.07 mmol), by following the general
procedure (1368C, 4 h), aldehyde 39a was obtained. Purification by chro-
matography (10–30% EtOAc/hexane) afforded 39a (21 mg, 0.05 mmol,
706
ꢂ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 697 – 709